We are AERA,


aera a/s is a European IP consultancy firm, built on Nordic values, but with an international perspective.

The term “aera” is derived from the Latin word that means “era” in English and “æra” in Danish. Our mission is also derived from our name – we want to create a new aera in IP consultancy.

Our clients come in all sizes – from the largest global companies to local entrepreneurs. What our clients all have in common is that they think big – and that they want to create a new aera within their fields of technology.

aeras patent attorneys have played significant roles in the creation and protection of landmark portfolios in the life science, medtech, and electronics industries.

We consider the commercial and technical issues – just as clearly as the legal issues.

This is why clients make us their first call, when they require a range of services that include IP counselling, prosecution, litigation, and patent strategy – or simply just to discuss important business decisions.

We take good care of innovators.


After decades of discussion, the implementation of a so-called “Unitary Patent Package”, i.e. the establishment of a Unitary Patent (UP) and a Unified Patent Court (UPC), has reached its final stages.

The Unitary Patents goal is to provide a single approach to European patent protection, and thus also enforcement across European Union Member States with a combined population of almost 500 million.

Utilizing the existing European patent application procedure, a Unitary Patent will be administered centrally by the European Patent Office. After grant, a Unitary Patent will be enforceable throughout the participating Member States in a single action brought before the new Unified Patent Court (UPC).

The UPC structure will have several Courts of First Instance consisting of Local, Regional and Central Divisions in various locations, along with a Court of Appeal based in Luxembourg.

The Central Division of the UPC will have exclusive jurisdiction over declarations of non-infringement and revocation actions (other than counterclaims), whereas local and regional divisions will be responsible for infringement actions and counterclaims for revocation.

Only the UK and Germany are now required to ratify the Unified Patent Court Agreement for it to come into effect.

However, the ratification in both countries has been delayed. The delays in UK ratification are following the UK General Election and Brexit, and the German ratification is being held up in the Constitutional Court.

The earliest start is therefore expected to be medio 2018, and likely later.

Since the United Kingdom voted to leave the European Union (now commonly known as “Brexit”) there has been a lot of uncertainty in terms of the future of the Unitary Patent Package, especially with regards to its enforceability in the UK.

What we know right now, is that when (or if?) the UK in fact leaves the EU several changes will be required to the UPC Agreement governing the UP and UPC. For example, additional rules on jurisdiction and enforcement will be needed.

Furthermore, if the UK decides to leave the EU without acknowledging the jurisdiction European Court of Justice, then it is hard to imagine how the UK based attorneys will continue to be able to represent clients in the Unified Patent Court.

Some have speculated that such challenges could be dealt with as part of a Brexit negotiations between the UK and EU – but uncertainty will increase if no deal can be made.

aera will of course be monitoring the progress in the negotiations, and will update all clients, in due course.

Our specialist UPC team – with experienced European Patent Attorneys that can represent clients in the future UPC court – is naturally also on hand to guide you through these changes, helping you enforce your patent rights.

Please contact your usual aera attorney, who can begin helping you plan for these important developments.

Our Biotechnology, Pharmaceuticals, and Chemistry team is made up of highly experienced European Patent Attorneys, several with research experience in academia or industry. They have worked with companies at every stage, from early start-ups to multinationals – and they share track records in meeting the commercial objectives of their clients.

The importance of intellectual property rights within these sectors cannot be overstated.

Innovation, and innovating with success, is a complex process. Especially the early stages carry a significant level of financial risk.

Securing patent rights, as well as optimizing, the financial benefits from innovation within these sectors through the correct deployment of intellectual property rights is therefore essential.

These are issues which the attorneys at aera fully understand. Our European Patent Attorneys have decades of experience developing and implementing tailored IP strategies to help ambitious and innovative companies of all sizes achieve commercial success.

We have a long history of providing strategic advice, from assisting with developing a business plan through to ensuring IP portfolios are structured with the commercial goals in mind. These goals can be to attract private or venture capital funding, secure licensing deals, or exit via a sale. Our track record includes supporting clients preparing for IPO, and we have advised on a number of successful trade sales.

aera has many direct clients. This inevitably means that we manage and coordinate the prosecution of patent applications all over the world – with the support of our large network of overseas attorneys.

As a result, we are experienced in navigating the legal challenges presented by the different implementation of patent law in foreign jurisdictions – which can be particularly challenging in the life-science fields.

We also prosecute a large number of cases from foreign associates, and help to secure and defend Scandinavian and European patent rights for international life-science companies, universities, and even governments.

Our clients value the intelligence and creativity of our attorney’s philosophy, and also the commercial approach we use to identifying, protecting and maximizing IP for our clients.

The strong technical expertise of our Biotechnology, Pharmaceuticals, and Chemistry team covers all aspects, including:

  • Pharmaceuticals
  • Industrial Biotechnology
  • Clinical Medicine
  • Diagnostics
  • Immunology
  • Organic Chemistry.

In addition to strong academic backgrounds in biosciences, our attorneys have significant industrial experience and understand the legal, technical and commercial challenges faced by companies in the global life-science sector. We support our clients with a complete range of IP services, including:

  • Opposition and Appeal
  • Invention Scouting
  • Patent Drafting
  • Filing & Prosecution
  • Supplementary Protection Certificates (SPCs)
  • Plant Variety Rights
  • Due Diligence
  • Freedom to Operate.

Our specialists within mechanics, electronics and software offer outstanding scientific and legal qualifications backed up by hands-on experience – including from their own industry background.

Highly qualified scientific thinking and specialized legal expertise helps us create strategies that support your commercial objectives.

As with all our key industry sectors, aera offers a full range of drafting and prosecution services for patents and registered designs, together with oppositions and appeals procedures.

The strong technical expertise of our mechanics, electronics and software team covers all aspects, including:

  • Wireless communications
  • Photonics
  • IoT
  • Cryptography
  • Blockchain technology
  • Machine learning techniques
  • AI
  • Materials science
  • Big data
  • Software-related inventions
  • Business methods
  • Telecommunication
  • Process and production technology.

In addition to strong academic backgrounds in mechanical and electronic sciences, our attorneys have significant industrial experience and understand the legal, technical and commercial challenges faced by companies in the global Electronics and IT sector. We support our clients with a complete range of IP services, including:

  • Invention Scouting
  • Patent Drafting
  • Filing & Prosecution
  • Opposition and Appeal
  • Due Diligence
  • Freedom to Operate.

Medical technology (or MedTech) is a field where innovation and development is changing and expanding very quickly, and the industry is experiencing unprecedented levels of competition.

Many established companies and smaller start-ups are now developing service-driven solutions using ‘smart’ devices for better management or treatment of complex conditions.

At the core of the MedTech field are technologies which we at aera have specialized in handling. We often combine in MedTech teams working across different technological areas to optimally service our clients developing e.g. medical devices and data-based diagnostics.

The strong technical expertise of our MedTech team covers many aspects, including:

  • Wound healing systems
  • Medical devices such as hearing aids and ostomy pouching systems
  • Biomaterials such as stents, including dental, ophthalmic and orthopaedic materials
  • Nebulisers and drug delivery systems
  • Implantable sensors and other diagnostic instruments
  • Surgical instruments including electrosurgical devices
  • Catheters, syringes and other medical disposables.

In addition to strong academic backgrounds in biosciences and engineering, we have significant industrial experience and understand the legal, technical and commercial challenges faced by companies in the global medical technology sector, and are able to support our clients with a complete range of IP services, including:

  • Invention Scouting
  • Patent Drafting
  • Filing & Prosecution
  • Opposition and Appeal
  • Supplementary Protection Certificates (SPCs)
  • Due Diligence
  • Freedom to Operate.


aera is always looking for talent

We don’t care if you have 3 or 15 years’ experience.

What we care about is whether you:

  • have a passion for inventions and patents,
  • if you can picture yourself driving projects forward for our clients,
  • build relations,
  • be part of an expanding company, and
  • have fun while doing it.

The recruitment process will depend on who you are, and the situation you are in.

We of course understand and respect the need for discretion if you already have an exciting job. In fact, we prefer it if you’re already successful with strong results.

Please contact one of the partners, or alternatively info@aera-ip.com, if you have any questions about the process – or if you are curious about how it is to work at aera.

aera a/s
Gammel Kongevej 60
18th floor
DK-1850 Frederiksberg C

Email   info@aera-ip.com

VAT: 39154765
Bank: Nordea A/S
Account: 2148 – 6896 549 101
IBAN: DK63 2000 6896 5491 01

aera a/s
Gammel Kongevej 60, 18th floor
DK-1850 Frederiksberg C


Represented by:
Nicka Kirstejn, Managing Partner


This site is owned by aera a/s, and is for commercial and informational purposes only. The content is not intended as legal advice, and it should not be used as such.

aera a/s will at all times do its utmost to keep this site fully updated. However, aera a/s disclaims any direct or indirect damage resulting from entering this site, or using the information contained in the site.

Material from this site can only be reproduced, distributed, or otherwise made public with prior permission from aera a/s.